Solid Biosciences (SLDB) Interest Expenses (2023 - 2025)
Quarterly results put Interest Expenses at $5000.0 for Q4 2025, down 93.33% from a year ago — trailing twelve months through Mar 2026 was -$271000.0 (down 186.58% YoY), and the annual figure for FY2025 was -$203000.0, down 159.71%.
Solid Biosciences has reported Interest Expenses over the past 3 years, most recently at $5000.0 for Q4 2025.
- Interest Expenses reached $5000.0 in Q4 2025 per SLDB's latest filing, up from -$336000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $121000.0 in Q1 2023 and bottomed at -$336000.0 in Q3 2025.
- Median Interest Expenses over the past 3 years was $85000.0 (2024), compared with a mean of $48000.0.
- The largest annual shift saw Interest Expenses decreased 20.72% in 2024 before it crashed 509.76% in 2025.
- Over 3 years, Interest Expenses stood at $101000.0 in 2023, then decreased by 25.74% to $75000.0 in 2024, then tumbled by 93.33% to $5000.0 in 2025.
- Business Quant data shows Interest Expenses for SLDB at $5000.0 in Q4 2025, -$336000.0 in Q3 2025, and $60000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -332,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -336,000.00 |
| Sep 30, 2025 | -336,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 106,000.00 |
| Sep 30, 2023 | 106,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |